U.S. markets open in 5 hours 6 minutes

Nymox Pharmaceutical Corporation (NYMX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0800+0.0400 (+1.96%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 9/18/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.56
52-Week Change 3-21.54%
S&P500 52-Week Change 333.58%
52 Week High 33.5000
52 Week Low 31.2500
50-Day Moving Average 31.9788
200-Day Moving Average 31.8718

Share Statistics

Avg Vol (3 month) 3232.26k
Avg Vol (10 day) 365.96k
Shares Outstanding 583.73M
Implied Shares Outstanding 6N/A
Float 848.34M
% Held by Insiders 144.97%
% Held by Institutions 12.52%
Shares Short (Sep 14, 2021) 42.58M
Short Ratio (Sep 14, 2021) 47.18
Short % of Float (Sep 14, 2021) 45.33%
Short % of Shares Outstanding (Sep 14, 2021) 43.08%
Shares Short (prior month Aug 12, 2021) 42.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-203.40%
Return on Equity (ttm)-692.40%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1k
EBITDA -12.44M
Net Income Avi to Common (ttm)-12.61M
Diluted EPS (ttm)-0.1620
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.2M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)316k
Total Debt/Equity (mrq)6.71
Current Ratio (mrq)3.83
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)-10.28M
Levered Free Cash Flow (ttm)-5.57M